Albumin Market Applications, Dynamics, Development Status and Outlook 2030
Talorsmith2821 Nov, 2022News
Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the albumin (as excipient) market. For instance, in 2014, Novozymes Biopharma DK A/S announced that its albumin-based VELTIS technology is used by GlaxoSmithKline plc in the manufacturing of type II diabetes drug (Tanzeum and Eperzan) in Europe.
Related Bookmarks
- Steam Autoclave Market Competitive Landscape and Market Poised for Rapid Growth by 2030
- Genotyping Market Share, Key Players Review, Demand and Upcoming Trend by Forecast to 2030
- Houston SEO Services Can Help Businesses Grow Online
- Genotyping Market Size, In-Depth Analysis, Specifications and Forecast to 2030
- Genotyping Market Size, Technological Advancement, Development Status and Strategic Assessment 2030
- Genotyping Market Applications, Dynamics, Development Status and Outlook 2030
- Genotyping Market Demands, Overview, Component, Market Revenue and Forecast by 2030
- Aptamers Market Trends, Key Players Review, Demand and by Forecast to 2030
- Aptamers Market Size, Grow with a Healthy CAGR During Forecast Period 2030
- Aptamers Market Opportunities, Demand, Growth, Application and Forecast to 2030
Recent Profiles
Kojaram Ias Academy
Bl555
Jasmine Amara
B52clubappp
Skyline Taxi Dubai To Abu Dhabi
Nobleviewmedia
789club – Cổng Game Bài
Best T Shirts Usa
Dorman Removals Croydon - Man And Van
Xôi Lạc